Huxtable RJ: Physiological actions of taurine. Physiol Rev. 1992, 72: 101-163.
CAS
PubMed
Google Scholar
Tappaz ML: Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem Res. 2004, 29: 83-96. 10.1023/B:NERE.0000010436.44223.f8.
Article
CAS
PubMed
Google Scholar
Lambert IH: Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochem Res. 2004, 29: 27-63. 10.1023/B:NERE.0000010433.08577.96.
Article
CAS
PubMed
Google Scholar
Foos TM, Wu JY: The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem Res. 2002, 27: 21-26. 10.1023/A:1014890219513.
Article
CAS
PubMed
Google Scholar
Chapman GE, Greenwood CE: Taurine in nutrition and brain development. Nutr Res. 1988, 8: 955-968. 10.1016/S0271-5317(88)80135-0.
Article
CAS
Google Scholar
Sturman JA: Taurine in development. J Nutr. 1988, 118: 1169-1176.
CAS
PubMed
Google Scholar
Jansson T: Amino acid transporters in the human placenta. Pediatr Res. 2001, 49: 141-147. 10.1203/00006450-200102000-00003.
Article
CAS
PubMed
Google Scholar
Kulanthaivel P, Cool DR, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V: Transport of taurine and its regulation by protein kinase C in the JAR human placental choriocarcinoma cell line. Biochem J. 1991, 277: 53-58.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ramamoorthy S, Leibach FH, Mahesh VB, Han H, Yang-Feng T, Blakely RD, Ganapathy V: Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. Biochem J. 1994, 300: 893-900.
Article
PubMed Central
CAS
PubMed
Google Scholar
Norberg S, Powell TL, Jansson T: Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Pediatr Res. 1998, 44: 233-238. 10.1203/00006450-199808000-00016.
Article
CAS
PubMed
Google Scholar
Lyall F, Greer I, Young A, Myatt L: Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta. 1996, 17: 165-168. 10.1016/S0143-4004(96)80009-9.
Article
CAS
PubMed
Google Scholar
Rubin E: Essential Pathology. 2001, Maryland: Lippincott Williams&Wilkins
Google Scholar
Kitano T, Iizasa H, Terasaki T, Asashima T, Matsunaga N, Utoguchi N, Watanabe Y, Obinata M, Ueda M, Nakashima E: Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs. J Cell Physiol. 2002, 193: 208-218. 10.1002/jcp.10165.
Article
CAS
PubMed
Google Scholar
Kitano T, Iizasa H, Hwang IW, Hirose Y, Morita T, Maeda T, Nakashima E: Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood-placenta barrier. Biol Pharm Bull. 2004, 27: 753-759. 10.1248/bpb.27.753.
Article
CAS
PubMed
Google Scholar
Lee NY, Choi HM, Kang YS: Choline transport via choline transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT. Placenta. 2009, 30: 368-374. 10.1016/j.placenta.2009.01.011.
Article
CAS
PubMed
Google Scholar
Mochizuki T, Satsu H, Shimizu M: Signaling pathways involved in tumor necrosis factor α-induced upregulation of the taurine transporter in Caco-2 cells. FEBS Letters. 2005, 579: 3069-3074. 10.1016/j.febslet.2005.04.063.
Article
CAS
PubMed
Google Scholar
Molchanova SM, Oja SS, Saransaari P: Mechanisms of enhanced taurine release under Ca2+ depletion. Neurochem Int. 2005, 47: 343-349. 10.1016/j.neuint.2005.04.027.
Article
CAS
PubMed
Google Scholar
Kang YS, Ohtsuki S, Takanaga H, Tomi M, Hosoya KI, Terasaki T: Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-α, taurine and hypertonicity. J Neurochem. 2002, 83: 1188-1195. 10.1046/j.1471-4159.2002.01223.x.
Article
CAS
PubMed
Google Scholar
Chang RCC, Stadlin A, Tsang D: Effects of tumor necrosis factor alpha on taurine uptake in cultured rat astrocytes. Neurochem Int. 2001, 38: 249-254. 10.1016/S0197-0186(00)00082-6.
Article
CAS
PubMed
Google Scholar
Han X, Budreau AM, Chesney RW: Cloning and characterization of the promoter region of the rat taurine transporter (TauT) gene. Adv Exp Med Biol. 2000, 483: 97-108. full_text.
Article
CAS
PubMed
Google Scholar
Bannai S: Induction of cystine and glutamate transport activity in human fibroblast by diethyl maleate and other electrophilic agents. J Biol Chem. 1984, 259: 2435-2440.
CAS
PubMed
Google Scholar
Hosoya KI, Saeki S, Terasaki T: Activation of carrier-mediated transport of L-cystine at the blood-brain and blood-retinal barriers in vivo. Microvasc Res. 2001, 62: 136-142. 10.1006/mvre.2001.2328.
Article
CAS
PubMed
Google Scholar
Kim HW, Kim JH, An HS, Park KK, Kim BK, Park T: Myo-inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7. Life Sci. 2003, 73: 2477-2489. 10.1016/S0024-3205(03)00656-8.
Article
CAS
PubMed
Google Scholar
Romio L, Zegarra-Moran , Varesio L, Galietta LJV: Regulation of taurine transport in murine macrophages. Amino Acids. 2001, 21: 151-160. 10.1007/s007260170022.
Article
CAS
PubMed
Google Scholar
O'Flaherty L, Stapleton PP, Redmond HP, Bouchier-Hayes D: Dexamethasone and lipopolysaccharide regulation of taurine transport in Caco-2 cells. J Surg Res. 1997, 69: 331-336. 10.1006/jsre.1997.5067.
Article
PubMed
Google Scholar
Meng TC, Fukada T, Tonks NK: Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell. 2002, 9: 387-399. 10.1016/S1097-2765(02)00445-8.
Article
CAS
PubMed
Google Scholar
Voss JW, Pedersen SF, Christensen ST, Lambert IH: Regulation of the expression and subcellular localization of the taurine transporter TauT in mouse NIH3T3 fibroblasts. Eur J Biochem. 2004, 271: 4646-4658. 10.1111/j.1432-1033.2004.04420.x.
Article
CAS
PubMed
Google Scholar
Kazanietz MG, Areces LB, Bahador A, Mischak H, Goodnight J, Mushinski JF, Blumberg PM: Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol Pharmacol. 1993, 44: 298-307.
CAS
PubMed
Google Scholar
Kulanthaivel P, Leibach FH, Mahesh VB, Ganapathy V: Tyrosine residues are essential for the activity of the human placental taurine transporter. Biochem Biophys Acta. 1989, 985: 139-146. 10.1016/0005-2736(89)90358-1.
Article
CAS
PubMed
Google Scholar
Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F: Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension. 1996, 28: 488-493.
Article
CAS
PubMed
Google Scholar
Roggensack AM, Zhang Y, Davidge ST: Evidence for peroxynitrite formation in the vasculature of women with preclampsia. Hypertension. 1999, 33: 83-89.
Article
CAS
PubMed
Google Scholar
Khullar S, Greenwood SL, Mccord N, Glazier JD, Ayuk PTY: Nitric oxide and superoxide impair human placental amino acid uptake and increase Na+ permeability: implications for fetal growth. Free Radic Biol Med. 2004, 36: 271-277. 10.1016/j.freeradbiomed.2003.11.007.
Article
CAS
PubMed
Google Scholar
Roos S, Powell TL, Jansson T: Human placental taurine transporter in uncomplicated and IUGR pregnancies: cellular localization, protein expression, and regulation. Am J Physiol Regul Integr Comp Physiol. 2004, 287: R886-R893.
Article
CAS
PubMed
Google Scholar
Lee NY, Kang YS: The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-α. Brain Res. 2004, 1023: 141-147. 10.1016/j.brainres.2004.07.033.
Article
CAS
PubMed
Google Scholar